Jiangsu Hualv Biotechnology Group Co., Ltd.
2025 Annual Equity Distribution Implementation Announcement
The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Special Reminder:
-
The 2,346,600 shares held in the company's repurchase special securities account will not participate in this equity distribution.
-
The profit distribution plan for 2025 is as follows: based on the total share capital of 122,609,100 shares, deducting the shares held in the repurchase account, the base capital is 120,262,500 shares. A cash dividend of 5.00 RMB (including tax) will be distributed for every 10 shares to all shareholders, with an expected total cash dividend of 60,131,250.00 RMB (including tax). No bonus shares will be issued this year, and shares will be increased from the capital reserve at a rate of 3 shares for every 10 shares held, totaling 36,078,750 shares.
-
After the implementation of this equity distribution, the ex-rights and ex-dividend price will be calculated as follows:
- Cash dividend per 10 shares (including tax) = Total actual cash dividend / Total share capital * 10 = 60,131,250.00 / 122,609,100 * 10 = 4.904305 RMB (retained to six decimal places, truncated without rounding).
- Capital reserve increase per 10 shares = Total increased shares / Total share capital * 10 = 36,078,750 / 122,609,100 * 10 = 2.942583 shares (retained to six decimal places, truncated without rounding).
- Reference price for ex-rights and ex-dividend = (Closing price before ex-rights and ex-dividend - Cash dividend per share) / (1 + Capital reserve increase per share) = (Closing price before ex-rights and ex-dividend - 0.4904305) / (1 + 0.2942583) (retained to seven decimal places, truncated without rounding).
The 2025 annual equity distribution plan has been approved by the shareholders' meeting held on May 20, 2026. The relevant matters regarding the equity distribution are announced as follows: